Log in to save to my catalogue

Sumoylation in neurodegenerative diseases

Sumoylation in neurodegenerative diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11113377

Sumoylation in neurodegenerative diseases

About this item

Full title

Sumoylation in neurodegenerative diseases

Publisher

Basel: SP Birkhäuser Verlag Basel

Journal title

Cellular and molecular life sciences : CMLS, 2013-06, Vol.70 (12), p.2123-2138

Language

English

Formats

Publication information

Publisher

Basel: SP Birkhäuser Verlag Basel

More information

Scope and Contents

Contents

The yeast SUMO (small ubiquitin-like modifier) orthologue SMT3 was initially discovered in a genetic suppressors screen for the centromeric protein Mif2 (Meluh and Koshland in Mol Bio Cell 6:793–807,
1
). Later, it turned out that the homologous mammalian proteins SUMO1 to SUMO4 are reversible protein modifiers that can form isopeptide bonds...

Alternative Titles

Full title

Sumoylation in neurodegenerative diseases

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11113377

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11113377

Other Identifiers

ISSN

1420-682X

E-ISSN

1420-9071

DOI

10.1007/s00018-012-1158-3

How to access this item